Kimia Biosciences quarterly results and financials

Kimia Biosciences (BSE 530313)₹30.08−0.07%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Kimia Biosciences reported sales of ₹20.64 Cr, down 12.1% from Jun 2025, and net profit of ₹0.37 Cr, down 39.3% year on year. For the year to Mar 2026, sales were ₹115 Cr and net profit ₹7.02 Cr.

Sales (Jun 2026): ₹20.64 Cr
Net profit (Jun 2026): ₹0.37 Cr
Sales (FY Mar 2026): ₹115 Cr
Net profit (FY Mar 2026): ₹7.02 Cr
EPS (Jun 2026): ₹0.09
Borrowings (Mar 2026): ₹35.02 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Kimia Biosciences quarterly results

₹ crore unless stated; each column is a quarter.

Kimia Biosciences Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	24.10	26.05	30.21	22.30	28.05	29.99	38.09	23.48	33.84	29.98	27.10	20.64
Expenses	26.10	27.12	26.06	18.65	24.74	25.03	30.01	21.01	31.42	23.49	24.47	18.33
Operating Profit	−1.97	−1.06	4.17	3.72	3.38	5.01	8.19	2.54	2.53	6.57	2.67	2.36
OPM %	−8.1%	−4.0%	13.8%	16.6%	12.0%	16.7%	21.5%	10.8%	7.5%	21.9%	9.8%	11.4%
Other Income	0.65	0.59	0.31	0.09	0.38	0.43	0.45	0.86	−0.34	0.11	1.02	0.09
Interest	1.13	1.30	1.33	1.12	1.05	1.02	1.41	1.76	0.28	0.74	0.74	0.82
Depreciation	0.83	0.83	0.83	0.91	0.80	0.83	0.89	0.95	0.98	0.86	1.17	1.12
Profit before tax	−3.25	−2.59	2.29	1.77	1.90	3.58	6.33	0.68	0.94	5.05	1.75	0.48
Tax %	−25.2%	−25.1%	22.1%	19.6%	15.7%	−27.4%	68.5%	13.0%	−7.4%	−7.7%	78.9%	26.5%
Net Profit	−2.45	−1.96	1.81	1.45	1.62	4.58	2.00	0.61	1.03	5.45	0.38	0.37
EPS (Rs)	−0.53	−0.42	0.39	0.31	0.35	0.98	0.43	0.14	0.23	1.16	0.09	0.09

Kimia Biosciences profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Kimia Biosciences Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.00	0.99	75.75	93.67	106	132	124	129	105	119	115	112
Expenses	3.99	1.99	73.84	87.83	102	124	124	133	105	98.82	101	97.71
Operating Profit	−3.01	−1.01	2.01	6.01	4.01	8.01	1.01	−5.01	0.00	20.03	14.02	14.13
OPM %	−1,778.9%	−56.0%	3.2%	6.0%	4.2%	6.0%	0.5%	−3.9%	−0.5%	17.1%	12.0%	12.7%
Other Income	0.00	0.00	1.01	1.01	1.01	2.01	1.01	0.00	2.01	1.01	2.01	0.88
Interest	1.01	0.00	0.99	2.01	2.99	3.01	4.01	3.99	4.99	5.01	3.99	2.58
Depreciation	0.00	0.00	1.01	1.01	2.01	2.01	3.01	3.01	3.01	3.01	4.01	4.13
Profit before tax	−3.99	−0.99	1.99	3.99	0.99	5.99	−4.99	−11.97	−6.98	13.98	7.98	8.22
Tax %	0.0%	−8.1%	−4.0%	−1.0%	−13.0%	8.0%	−26.1%	−25.0%	−26.1%	28.9%	11.9%	—
Exceptional items	0.00	−0.15	0.02	0.03	−0.02	0.08	0.09	−1.06	0.00	0.00	0.00	—
Net Profit	−4.01	−1.01	2.01	4.01	1.01	5.01	−4.01	−9.01	−5.01	10.02	7.02	7.23
EPS (Rs)	−5.49	−1.27	2.27	2.65	0.31	1.09	−0.79	−1.99	−1.13	2.04	1.58	1.57
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Kimia Biosciences balance sheet

₹ crore, at each year end.

Kimia Biosciences Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7.01	7.01	7.01	1.01	1.01	5.02	5.01	5.01	5.01	5.02	5.01	5.01
Reserves	−6.99	−10.98	−11.99	0.00	3.99	8.97	13.98	9.98	0.99	−3.99	4.98	12.96
Borrowings	1.01	7.00	14.01	34.02	31.05	34.06	45.08	41.06	53.06	44.02	33.06	35.02
Other Liabilities	3.99	0.99	2.98	22.06	29.10	38.08	43.21	54.26	63.18	56.17	68.25	51.22
Total Liabilities	5.02	4.02	12.01	58.09	65.15	86.13	107	109	121	100	111	103
Fixed Assets	3.01	3.01	7.01	13.03	16.04	18.02	28.08	35.09	34.04	32.07	33.06	37.08
CWIP	0.00	0.00	2.99	1.99	1.99	5.99	5.99	0.00	0.99	0.99	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	1.01	1.01	2.01	43.07	48.12	62.12	72.21	74.22	87.21	68.16	78.24	66.13
Inventories	0.09	0.08	0.60	9.61	16.12	20.34	23.70	37.03	48.31	30.85	34.64	26.28
Trade receivables	0.26	0.08	0.07	29.46	29.09	37.29	41.69	30.14	30.55	27.49	36.66	29.28
Cash & equivalents	0.00	0.00	0.06	2.02	1.25	0.76	1.66	0.51	0.49	0.52	0.67	0.81
Total Assets	5.02	4.02	12.01	58.09	65.15	86.13	107	109	121	100	111	103

Kimia Biosciences cash flow

₹ crore, for each year.

Kimia Biosciences Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	—	−6.01	−1.01	−7.01	−3.01	0.00	6.01	8.01	−7.01	15.02	21.03	11.02
Cash from investing activity	—	0.00	−5.98	−1.99	−1.99	−8.97	−13.96	−0.99	−2.99	−0.99	−4.99	−7.98
Cash from financing activity	—	5.99	6.98	9.97	3.99	7.98	7.98	−7.98	9.98	−12.97	−16.96	−2.99
Net cash flow	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capex	0.00	0.09	6.31	2.76	2.57	8.99	13.51	3.57	2.80	1.50	4.59	8.14
Free cash flow	—	−5.99	−6.99	−9.99	−4.99	−8.99	−7.98	5.98	−9.99	12.97	16.97	2.99
CFO / OP %	—	177.0%	85.0%	−287.0%	−45.0%	5.0%	71.0%	1,281.0%	136.0%	−3,021.0%	105.0%	76.0%

Kimia Biosciences ratios

Working-capital days and returns, by year.

Kimia Biosciences Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	56	173	20	141	113	128	115	88	87	96	113	93
Inventory days	49	318	614	58	82	91	88	145	182	148	177	136
Days payable	666	90	510	119	90	120	115	158	176	193	259	219
Cash conversion cycle	−561	400	123	79	104	99	87	75	92	50	30	9
Working capital days	−529	−172	−1,357	49	63	74	54	32	17	−29	−21	6
ROCE %	−127.0%	−188.0%	−10.0%	10.0%	16.0%	9.0%	16.0%	−2.0%	−12.0%	−4.0%	42.0%	25.0%

Kimia Biosciences: frequently asked questions

What are the latest quarterly results of Kimia Biosciences?

For the Jun 2026 quarter, Kimia Biosciences reported sales of ₹20.64 Cr, down 12.1% year on year and net profit of ₹0.37 Cr, down 39.3% year on year. The operating margin was 11.4%.

What is the annual revenue of Kimia Biosciences?

Kimia Biosciences' sales for the year to Mar 2026 were ₹115 Cr; over the last twelve months they were ₹112 Cr.

What is the net profit of Kimia Biosciences?

Net profit for the year to Mar 2026 was ₹7.02 Cr, and ₹7.23 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.57.

How much debt does Kimia Biosciences have?

Kimia Biosciences reported borrowings of ₹35.02 Cr at Mar 2026, against cash and equivalents of ₹0.81 Cr.

What is the free cash flow of Kimia Biosciences?

Cash from operations was ₹11.02 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2.99 Cr.

Loading…